Teva Pharmaceutical Industries vs Waters

Teva Pharmaceutical Industries (TEVA), health care, and Waters (WAT), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Waters is worth $88.4B on the stock market and Teva Pharmaceutical Industries $49.7B: Waters is valued at 78% more. Teva Pharmaceutical Industries trades at 99.1 times earnings and Waters at 188; operating margins in their latest fiscal years were 12.5% and 25.4%. Over the past year Teva Pharmaceutical Industries's share price has moved +71.4% and Waters's +20.4%.

Key facts

Teva Pharmaceutical Industries market value
$49.7B
Waters market value
$88.4B
Teva Pharmaceutical Industries P/E
99.1
Waters P/E
188
Teva Pharmaceutical Industries revenue
$17.3BFY to 2025-12-31
Waters revenue
$3.2BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Teva Pharmaceutical Industries vs Waters: every measure side by side
Measure Teva Pharmaceutical Industries Waters
SectorHealth CareHealth Care
Country Israel United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$49.7Blower$88.4Bhigher
Revenue$17.3Bhigher$3.2Blower
Earnings$1.4Bhigher$642.6Mlower
Employees31,173higher15,000lower
Total assets$40.7Bhigher$5.1Blower
Valuation
P/E99.1lower188higher
P/S2.9lower27.9higher
P/B—2.9
Dividend yield—0.00%
Profitability
Operating margin12.5%lower25.4%higher
Balance sheet
Net assets$7.9Bhigher$2.6Blower
Total liabilities$32.8Bhigher$2.5Blower
Total debt—$1.4B
Cash on hand$3.6Bhigher$587.8Mlower
Price change
Today+0.12%higher-0.80%lower
1 year+71.4%higher+20.4%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio. Who owns TEVA · Who owns WAT

Further comparisons

Learn

Questions and answers

Which is bigger, Teva Pharmaceutical Industries or Waters?

By market value, Waters is the larger: $88.4B against $49.7B for Teva Pharmaceutical Industries. By revenue in its latest fiscal year, Teva Pharmaceutical Industries is the larger: $17.3B against $3.2B for Waters.

Which has the higher P/E ratio?

Waters: 188, against 99.1 for Teva Pharmaceutical Industries. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Waters: 25.4%, against 12.5% for Teva Pharmaceutical Industries. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which superinvestors own both Teva Pharmaceutical Industries and Waters?

None of the tracked superinvestors holds both in their latest 13F filing. 7 hold Teva Pharmaceutical Industries and 11 hold Waters.

Cite this page

Funkfolio, “Teva Pharmaceutical Industries vs Waters”, data as of 17 November 2026. https://funkfolio.com/compare/teva-vs-wat

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.